Lon Smith
South Texas Accelerated Research Therapeutics(US)Start Treatment & Recovery Centers(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology, Cancer Immunotherapy and Biomarkers, HER2/EGFR in Cancer Research
Most-Cited Works
- → Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial(2011)1,042 cited
- → Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors(2015)774 cited
- → The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer(2012)431 cited
- → Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.(1996)352 cited
- → Phase I and pharmacokinetic trial of weekly CPT-11.(1993)303 cited
- → Cantuzumab Mertansine, a Maytansinoid Immunoconjugate Directed to the CanAg Antigen: A Phase I, Pharmacokinetic, and Biologic Correlative Study(2003)204 cited